Number of mutations within CTL-defined epitopes of the hepatitis B Virus (HBV) core region is associated with HBV disease progression.
The virologic determinants of progressive liver disease associated with hepatitis B virus (HBV) remain unclear. Previous investigations have associated HBV disease with specific mutations but this association may be confounded by HBV genotype, HLA haplotype of the infected individual or both. The association between non-synonymous mutations located within putative cytotoxic T-lymphocyte directed epitopes (CDE) of the HBV core region and disease states was investigated. Subjects infected with HBV were enrolled from a clinical cohort in Seoul, Korea, and HBV core gene sequences were analyzed for mutational patterns inside and outside of CDE with respect to subject demographics and HBV-related disease states. No specific mutation or pattern of mutations were associated with progressive disease states; however, individuals with cirrhosis and hepatocellular carcinoma had greater numbers of non-synonymous mutations within CDE when compared to those with chronic HBV infection who were HBeAg positive (P = 0.007 and 0.026, respectively). In conclusion, this study demonstrates that HBV disease progression is associated with viral escape mutations that are a marker of CTL activity. These data suggest that the number of non-synonymous mutations in the HBV core region may predict HBV disease progression better than any single mutation or pattern of mutations.
University of California, La Jolla, CA, USA.
Daniel
D
Kim
Kwang Soo
KS
Lyoo
Davey
D
Smith
Wonhee
W
Hur
Sung Woo
SW
Hong
Pil Soo
PS
Sung
Seung Kew
SK
Yoon
Sanjay
S
Mehta
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000473:pathology / Q000821:virology; D002648:Child; D018450:Disease Progression; D018984:Epitopes, T-Lymphocyte / Q000235:genetics* / Q000276:immunology; D005260:Female; D006509:Hepatitis B / Q000150:complications / Q000473:pathology / Q000821:virology*; D006512:Hepatitis B Core Antigens / Q000235:genetics* / Q000276:immunology; D006515:Hepatitis B virus / Q000235:genetics* / Q000276:immunology / Q000472:pathogenicity*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications / Q000473:pathology / Q000821:virology; D008113:Liver Neoplasms / Q000150:complications / Q000473:pathology / Q000821:virology; D008297:Male; D008875:Middle Aged; D020125:Mutation, Missense; D056910:Republic of Korea; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D055815:Young Adult
D018984:Epitopes, T-Lymphocyte; D006512:Hepatitis B Core Antigens